NASDAQ:RXRX | EBITDA | RECURSION PHARMACEUTICALS, INC.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$108.83M
2025-12-31-$88.86M
2025-03-31-$172.04M
2024-12-31-$170.82M
2024-03-31-$88.96M
2023-12-31-$91.38M
2023-03-31-$66.14M
2022-12-31-$57.77M
2022-03-31-$53.21M
2021-12-31-$62.72M
2021-03-31-$29.08M
2020-12-31-$24.46M
2020-03-31-$17.41M

Annual EBITDA

DateEBITDA
2025-12-31-$564.43M
2024-12-31-$442.51M
2023-12-31-$325.66M
2022-12-31-$233.97M
2021-12-31-$174.37M
2020-12-31-$80.67M
2019-12-31-$59.95M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.